JP2003516358A - Melanin synthesis inhibitory compound and composition containing the melanin synthesis inhibitory compound - Google Patents

Melanin synthesis inhibitory compound and composition containing the melanin synthesis inhibitory compound

Info

Publication number
JP2003516358A
JP2003516358A JP2001543122A JP2001543122A JP2003516358A JP 2003516358 A JP2003516358 A JP 2003516358A JP 2001543122 A JP2001543122 A JP 2001543122A JP 2001543122 A JP2001543122 A JP 2001543122A JP 2003516358 A JP2003516358 A JP 2003516358A
Authority
JP
Japan
Prior art keywords
gomisin
composition
melanin synthesis
schizandrin
melanin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2001543122A
Other languages
Japanese (ja)
Inventor
スン,チャン,ケウン
パーク,ジョンホーン
ジュン,ヒュン,オー
リー,チャン,ホ
キム,ヨウン,ホ
ホン,セウン,スー
リー,ヒュン−ソー
Original Assignee
サムヤン ジェネックス コーポレイション
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by サムヤン ジェネックス コーポレイション filed Critical サムヤン ジェネックス コーポレイション
Publication of JP2003516358A publication Critical patent/JP2003516358A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/02Preparations for care of the skin for chemically bleaching or whitening the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/357Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/79Schisandraceae (Schisandra family)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4973Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4973Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
    • A61K8/498Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom having 6-membered rings or their condensed derivatives, e.g. coumarin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9728Fungi, e.g. yeasts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783Angiosperms [Magnoliophyta]
    • A61K8/9789Magnoliopsida [dicotyledons]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783Angiosperms [Magnoliophyta]
    • A61K8/9794Liliopsida [monocotyledons]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system

Abstract

(57)【要約】 本発明は、ゴミシンN又はγ-シザンドリンを含有するメラニン合成阻害化合物、並びに該化合物を含有する組成物に関する。本発明の組成物は、細胞毒性を示さずに優れたメラニン合成阻害効果を有する。本発明は、細胞毒性を示さずに優れたメラニン合成阻害効果を有する五味子抽出物にも関する。 (57) [Summary] The present invention relates to a melanin synthesis inhibitory compound containing gomisin N or γ-schizandrin, and a composition containing the compound. The composition of the present invention has an excellent melanin synthesis inhibitory effect without showing cytotoxicity. The present invention also relates to a Gomiko extract having excellent melanin synthesis inhibitory effect without showing cytotoxicity.

Description

【発明の詳細な説明】Detailed Description of the Invention

【0001】 〔発明の属する技術分野〕 本発明は、メラニン合成阻害効果がある化合物及び該化合物を含有する組成物
に関する。
TECHNICAL FIELD The present invention relates to a compound having a melanin synthesis inhibitory effect and a composition containing the compound.

【0002】 〔従来の技術〕 日光に皮膚が露出されると、紫外線を防ぐためにメラニン色素が合成される。
該メラニン色素が皮膚の表面に現れることで、皮膚が黒くなる。
[Prior Art] When the skin is exposed to sunlight, a melanin pigment is synthesized in order to prevent ultraviolet rays.
The skin becomes dark due to the appearance of the melanin pigment on the surface of the skin.

【0003】 前記メラニンは、自然界に広く分布されているフェノール類の生物高分子物質
としての黒い色素とタンパク質との複合体である。該メラニンは、物理・化学的
に黄色-赤褐色を示すフェオメラニン(pheomelanin)と、褐色-黒色のオイメラニ
ン(eumelanin)と、類似な特徴を有するトリコクローム(trichochrome)との3種類
に大別され、それらの生合成の経路は、全てチロシナーゼ(tyrosinase:EC1.14.
18.1)の作用により行われると報告されている。人間の皮膚色は、該色素の種類
及び量によって決定されて、該色素の過剰生産は、人間の皮膚に雀斑を形成して
、皮膚の老化を促進し、皮膚癌を誘発すると知られている。又、食品では野菜、
果物及び魚類の質を低下させることがある。
The melanin is a complex of a black pigment and a protein as a biopolymer substance of phenols widely distributed in nature. The melanin is physically and chemically yellow-pheomelanin showing a reddish brown color (pheomelanin), brown-black eumelanin (eumelanin), and trichochrome having similar characteristics (trichochrome), is roughly divided into three types, All of their biosynthetic pathways are tyrosinase (EC1.14.
It is reported to be carried out by the action of 18.1). Human skin color is determined by the type and amount of the pigment, and overproduction of the pigment is known to form freckles on the human skin, promote skin aging, and induce skin cancer. . Also, in food, vegetables,
May reduce fruit and fish quality.

【0004】 メラニン合成阻害剤は、医薬品、化粧品及び食品などの分野で、皮膚疾患の治
療剤、皮膚の美白剤及び食品の褐斑防止剤などに適用されてあり、最近、その需
要が急増されつつある。
Melanin synthesis inhibitors have been applied in the fields of pharmaceuticals, cosmetics, foods, etc., as therapeutic agents for skin diseases, skin whitening agents, brown spot inhibitors for foods, etc., and the demand for them has increased rapidly in recent years. It's starting.

【0005】 メラニン合成阻害剤に関する研究は、主にチロシナーゼ(tyrosinase)阻害剤
の開発に集中され、その結果、多様な美白剤が開発されて来たが、色々な問題点
が提起されている。
Studies on melanin synthesis inhibitors have mainly been focused on the development of tyrosinase inhibitors, and as a result, various whitening agents have been developed, but various problems have been raised.

【0006】 4-ヒドロキシアニゾール(hydroxyanizole)及びヒドロキノンは、雀斑及び妊娠
期の過剰症のような治療に局部的に適用されている。これらの化合物は、強力な
メラニン生成の阻害活性を現わすが、色素細胞の変性又は致死を起して、細胞本
来の機能を損傷させるなどの副作用があるために、一部の国のみで使用が許可さ
れている。コウジ酸[5-ヒドロキシ-2-(ヒドロキシメチル-γ-ピロン]、及びア
ルブチン(ヒドロキノン-β-D-グルコピラノシド)なども、アスコルビン酸と共に
食品の褐斑防止剤、化粧品及び医薬物用美白剤の成分として使用される主要活性
成分であるが、低い阻害活性、使用中の変色及び物質自体が不安定であるという
不都合な点があった。
4-Hydroxyanizole and hydroquinone have been applied topically for the treatment of spots and hypertension during pregnancy. Although these compounds show a strong inhibitory activity on melanin production, they have side effects such as degeneration or death of pigment cells and damage to the original functions of cells, so they are used only in some countries. Is allowed. Kojic acid [5-hydroxy-2- (hydroxymethyl-γ-pyrone), arbutin (hydroquinone-β-D-glucopyranoside), etc. are also used as an anticorrosive agent for food, as a whitening agent for cosmetics and pharmaceuticals, together with ascorbic acid. Although it is the main active ingredient used as an ingredient, it has the disadvantages of low inhibitory activity, discoloration during use and instability of the substance itself.

【0007】 韓国特許228741号は、五味子の抽出物(schizandra extract)を固形の飲食物に
配合してチロシアーゼの活性を阻害し、グルコシルトランスフェラーゼの活性を
阻害して歯の美白効果及び虫歯予防効果を有する五味子の抽出物が配合された固
形の飲食物を記載している。
Korean Patent No. 228741 discloses that schizandra extract is added to a solid food or drink to inhibit the activity of tyrocyanase and inhibits the activity of glucosyltransferase to have a whitening effect on teeth and a dental caries preventive effect. It describes a solid food or drink in which an extract of Gomizai is included.

【0008】 一方、ゴミシンNと前記γ-シザンドリンとは、相互立体異性質体であって構造
式は次のようである。
On the other hand, gomisin N and γ-schizandrin are mutual stereoisomers, and their structural formulas are as follows.

【0009】[0009]

【化1】 [Chemical 1]

【0010】[0010]

【化2】 [Chemical 2]

【0011】 ゴミシンNは、コレステロールアシルトランスフェラーゼの活性を阻害して(Pl
anta med.1999、65:74-76)、真菌類の細胞壁合成酵素であるキチナーゼ(chiti
nase)IIの活性を阻害すると報告されている(薬学会誌、1995、43(4):509-515)
Gomisin N inhibits the activity of cholesterol acyltransferase (Pl
anta med.1999, 65: 74-76), chitinase (chiti), a cell wall synthase of fungi.
nase) II activity has been reported to be inhibited (Journal of Pharmaceutical Sciences, 1995, 43 (4): 509-515).
.

【0012】 今日、γ-シザンドリンの生理活性は知られていない。[0012]   Today, the physiological activity of γ-schizandrin is unknown.

【0013】 〔発明が解決しようとする課題〕 本発明の目的は、メラニン阻害活性を有する五味子抽出物を提供することであ
る。
[Problems to be Solved by the Invention] An object of the present invention is to provide an extract of Schisandra moriensis having melanin inhibitory activity.

【0014】 本発明の目的は、メラニンの合成を阻害する化合物を提供し、該メラニンの合
成を阻害する組成物を提供することを目的とする。
An object of the present invention is to provide a compound that inhibits the synthesis of melanin, and to provide a composition that inhibits the synthesis of the melanin.

【0015】 〔課題を解決するための手段〕 本発明は、五味子抽出物を含有するメラニン合成阻害剤に関する。本発明の五
味子抽出物は、好ましくは、ゴミシンN又はγ-シザンドリンを含有する。本発明
は、ゴミシンN又はγ-シザンドリンを含有するメラニン合成阻害剤にも関する。
[Means for Solving the Problems] The present invention relates to a melanin synthesis inhibitor containing a garlic extract. The schizandra extract of the present invention preferably contains gomisin N or γ-schizandrin. The present invention also relates to a melanin synthesis inhibitor containing gomisin N or γ-schizandrin.

【0016】 本発明者らは、ゴミシンN及びγ-シザンドリンは、細胞毒性が殆どなくて、美
白効果が優れていることを発見した。
The present inventors have discovered that gomisin N and γ-schizandrin have almost no cytotoxicity and an excellent whitening effect.

【0017】 即ち、ゴミシンN及びγ-シザンドリンは、美白効果がある従来の物質、例えば
、コウジ酸及びアルブチンに比べてチロシンの阻害活性が大いに低いため、ゴミ
シンN及びγ-シザンドリンのメラニン活性が、チロシナーゼの阻害によるメカニ
ズムでないことが分かる。
That is, since gomisin N and γ-schizandrin have much lower tyrosine inhibitory activity than conventional substances having a whitening effect, for example, kojic acid and arbutin, the melanin activity of gomisin N and γ-schizandrin is It is understood that it is not a mechanism by the inhibition of tyrosinase.

【0018】 又、抗酸化活性が低いので、ゴミシンN及びγ-シザンドリンは、チロシンから
開始されるメラニン合成段階の酸化過程を阻害することはないことが分かる。又
、ゴミシンN及びγ-シザンドリンは、細胞に対する細胞毒性を見せなくて、色素
合成のみを選択的に阻害する。
Further, it can be seen that gomisin N and γ-schizandrin do not inhibit the oxidative process of melanin synthesis stage initiated from tyrosine because of its low antioxidant activity. Gomisin N and γ-schizandrin do not show cytotoxicity to cells and selectively inhibit only pigment synthesis.

【0019】 ゴミシンN及びγ-シザンドリンは、生物体から抽出するか又は、合成及びその
他の知られた方法により製造することができるし、例えば、ゴミシンN及びγ-シ
ザンドリンを、五味子から抽出することができる。
Gomisin N and γ-schizandrin can be extracted from organisms or produced by synthetic and other known methods, for example, gomisin N and γ-schizandrin can be extracted from Schisandra chinensis. You can

【0020】 本発明に係るゴミシンN及びγ-シザンドリンの含有組成物は、メラニン合成阻
害剤として使用することができるし、化粧品、医薬用美白剤及び食品褐斑剤とし
て利用することもできる。本発明に係る組成物の具体的な組成は、当業者により
容易に決定することができる。
The composition containing gomisin N and γ-schizandrin according to the present invention can be used as a melanin synthesis inhibitor, and can also be used as a cosmetic, a pharmaceutical whitening agent and a food browning agent. The specific composition of the composition according to the present invention can be easily determined by those skilled in the art.

【0021】 本発明において美白剤の活性を確認するために使用した活性測定方法は次のよ
うである。
The activity measuring method used for confirming the activity of the whitening agent in the present invention is as follows.

【0022】 チロシナーゼ活性の阻害能の測定 チロシナーゼ活性の阻害能の測定は、35℃水槽で温度を予め調整したリン酸緩
衝液(pH6.8)50mM1.5mlにチロシン(シグマ社、米国)を0.1mg/mlの濃度で添加し、
チロシナーゼ(EC1.14.18.1;4,400単位/mg粉末、シグマ社)110単位/mlを添加し
た。ここで、濃度別に希釈した試料を加えて37℃で10分間反応させた後、475nm
で吸光度を測定した値をSAbs に、酵素液の代わりに蒸留水を加えて吸光度を測
定した値をBAbsに、抽出試料の変わりに蒸留水を加えて吸光度を測定した値をCA
bs にして次の式により阻害率を計算した。
Measurement of Inhibitory Ability of Tyrosinase Activity To measure the inhibitory ability of tyrosinase activity, tyrosine (Sigma, USA) was added to 0.1 ml of tyrosine (Sigma Co., USA) in 1.5 ml of phosphate buffer (pH 6.8) whose temperature was previously adjusted in a 35 ° C. water bath. added at a concentration of mg / ml,
Tyrosinase (EC 1.14.18.1; 4,400 units / mg powder, Sigma) 110 units / ml was added. Here, after adding samples diluted according to concentration and reacting at 37 ° C for 10 minutes, 475 nm
The value obtained by measuring the absorbance with SAbs, the value obtained by adding the distilled water instead of the enzyme solution to measure the absorbance is BAbs, and the value obtained by adding the distilled water instead of the extracted sample to measure the absorbance with CA
The inhibition rate was calculated by the following formula with bs.

【0023】[0023]

【数1】 [Equation 1]

【0024】 硫酸化活性の測定 化合物の硫酸化活性は、各化合物0.1mgをメタノール0.1mlに溶かして、リノレ
ン(linoleic)酸58mgが溶かされたエタノール5mlに加えて、これに0.2M燐酸緩
衝液(pH7.0)5ml及び蒸留水を加えて12mlに合わせ、40℃の培養基に放置する。24
時間後、75%のエタノール7mlに反応液0.1ml、0.02MFeCl2 溶液150μlと30%のチ
オシアン酸アンモニウム150μlとを3分間反応させて500nmで吸光度を測定した。
Measurement of Sulfation Activity The sulfation activity of each compound was measured by dissolving 0.1 mg of each compound in 0.1 ml of methanol and adding to 5 ml of ethanol containing 58 mg of linoleic acid. (pH 7.0) 5 ml and distilled water are added to adjust to 12 ml, and the mixture is left to stand in a culture medium at 40 ° C. twenty four
After a lapse of time, 7 ml of 75% ethanol was reacted with 0.1 ml of the reaction solution, 150 μl of 0.02M FeCl 2 solution and 150 μl of 30% ammonium thiocyanate for 3 minutes, and the absorbance was measured at 500 nm.

【0025】 ストレプトミセス・ビキニエンシス(Streptomyes bikiniensis)メラニン合成 に対する阻害活性の測定 S.bikiniensis KCTC 9172をV-8ジュース200ml、グルコース2g、酵母エキス2
g、CaCO31g、2g及びバクトアガ(bacto agar)蒸留水800mlを含有したpH7.2のパ
パビザス(Papavizas)VDYA斜面培地に接種する。28℃で二日間培養した斜面培養
物の表面に2mlの蒸留水を加えた後、気菌糸に形成された胞子を白金耳で掻き出
して胞子懸濁液を作った。
Measurement of inhibitory activity against Streptomyes bikiniensis melanin synthesis S. bikiniensis KCTC 9172 200 ml V-8 juice, glucose 2 g, yeast extract 2
Inoculate Papavizas VDYA slant medium at pH 7.2 containing g, CaCO 3 1 g, 2 g and bacto agar distilled water 800 ml. After adding 2 ml of distilled water to the surface of the slant culture cultivated at 28 ° C for 2 days, spores formed on aerial mycelia were scraped off with a platinum loop to prepare a spore suspension.

【0026】 グルコース1.5%、L-チロシン0.5%、L-アスパラギン0.1%、K2HPO40.05%、MgSO4 ・7H2O 0.05%、NaC1 0.05%、FeSO4×7H2O 0.001%、バクトアガ(bacto agar)
2%を含有したチロシン寒天培地組成にバクト酵母エキス(bacto-yeast extract)
0.2%を添加して固体培地を作り滅菌した後、シャーレに平板培地を調製する。寒
天プレート当り0.4mlのS.bikiniensis胞子懸濁液を加えて均一に塗布して、50μ
lの試料を浸した8mm直径のペーパーディスクを載置して28℃の条件で48時間培養
する。
[0026] 1.5% glucose, 0.5% L-tyrosine, L- asparagine 0.1%, K 2 HPO 4 0.05 %, MgSO 4 · 7H 2 O 0.05%, NaC1 0.05%, FeSO 4 × 7H 2 O 0.001%, Bakutoaga ( bacto agar)
Bacterial yeast extract (bacto-yeast extract) in tyrosine agar medium composition containing 2%
0.2% is added to make a solid medium and sterilized, and then a plate medium is prepared in a petri dish. Add 0.4 ml of S. bikiniensis spore suspension per agar plate and apply evenly,
Place an 8 mm diameter paper disk soaked with 1 l of sample and incubate at 28 ° C for 48 hours.

【0027】 メラニン生成阻害により生成されたゾーンの大きさを上記プレートの背面で計
測する。対照群としてはp-ヒドロキシアニソールを使用した。
The size of the zone produced by the inhibition of melanin production is measured on the back side of the plate. As a control group, p-hydroxyanisole was used.

【0028】 アスペルギルス・ニガー(Aspergillus niger)胞子のメラニン合成阻害活性の 測定 A.niger KCTC 2118をポテトデキストロース寒天培地(ポテト20%、デキスト
ロース2%、寒天1.5%;PDA培地)に37℃の温度下で6日間培養した後、プレートの
表面に10mlの0.01%Tween80(商標)溶液を加えて菌糸に形成された胞子を掻き出し
て胞子懸濁液を作る。胞子懸濁液をPDA培地に5%になるように添加した後、培地
を24ウェルに1mlずつ入れて固めて試料を50μlのエタノールに溶かしてプレート
の表面に直接加えた後、37℃の温度下で二日間培養して胞子の色素合成を肉眼で
観察した。胞子懸濁液1ml当り胞子数は、1.5×105CFUになるように調整する。対
照群としてp-ヒドロキシアニゾールを使用した。
Measurement of melanin synthesis inhibitory activity of Aspergillus niger spores A. niger KCTC 2118 was added to potato dextrose agar medium (potato 20%, dextrose 2%, agar 1.5%; PDA medium) at a temperature of 37 ° C. After culturing for 6 days at 10 ° C., 10 ml of 0.01% Tween 80 ™ solution is added to the surface of the plate to scrape the spores formed on the hyphae to make a spore suspension. After adding the spore suspension to PDA medium at 5%, add 1 ml of medium to 24 wells, solidify and dissolve the sample in 50 μl of ethanol and add it directly to the surface of the plate. After culturing for 2 days, the spore pigment synthesis was visually observed. Adjust the number of spores per ml of spore suspension to 1.5 x 10 5 CFU. P-Hydroxyanisole was used as a control group.

【0029】 メラノーマ細胞のメラニン合成阻害活性の測定 B16マウスメラノーマ細胞を5×103細胞/mlの動度で10%FCS(fetal chalf ser
um)を包含するDMEM(Dulbescco's Modified Eagle's Medium、Gibco BRL)培
地に懸濁させた後、懸濁細胞5mlを組織培養用フラスコ(Falcon、Becton dickin
son)に入れて黒色試料を濃度別に添加した後、5%CO2-95%の空気条件下で、37℃
で培養する。4日間培養した後、フラスコの底面に吸着された細胞をリン酸緩衝
生理食塩水(phosphate buffered saline、PBS)で洗った後、0.05%トリプシン
、0.53mM EDTA溶液で細胞を剥離して1500rpmで10分間遠心分離してチューブに
集めた後、細胞の色をアルブチンを添加した対照群と肉眼で比較する。
Measurement of melanin synthesis inhibitory activity of melanoma cells B16 mouse melanoma cells were treated with 10% FCS (fetal chalf serr) at a mobility of 5 × 10 3 cells / ml.
um) suspended in DMEM (Dulbescco's Modified Eagle's Medium, Gibco BRL) medium containing (um), 5 ml of suspended cells (Falcon, Becton dickin)
son) and adding black samples by concentration, and then at 37 ° C under 5% CO 2 -95% air conditions.
Culture at. After culturing for 4 days, the cells adsorbed on the bottom of the flask were washed with phosphate buffered saline (PBS), and then the cells were detached with 0.05% trypsin and 0.53 mM EDTA solution, and 1500 rpm 10 After centrifuging and collecting in a tube, the color of the cells is visually compared with the control group supplemented with arbutin.

【0030】 又、前記遠心分離して得られた細胞に5%のトリクロロ酢酸(TCA)を処理して攪
拌して遠心分離した後、メラニンを沈殿させる。メラニンをリン酸緩衝生理食塩
水で洗浄する。次いで、水酸化ナトリウム1N1mlを加えて10分間煮てメラニンを
溶かして分光光度計により、400nmで吸光度を測定して生成されたメラニンの量
を単位細胞数当り(106細胞)の吸光度に表す方法により、対照群に対する相対的
なメラニン生成量を阻害率(%)に計算してIC50を求めた。
The cells obtained by centrifugation are treated with 5% trichloroacetic acid (TCA), stirred and centrifuged, and then melanin is precipitated. The melanin is washed with phosphate buffered saline. Then, add 1 ml of sodium hydroxide 1N and boil for 10 minutes to dissolve melanin, and measure the absorbance at 400 nm with a spectrophotometer to express the amount of melanin produced per unit cell number (10 6 cells) as a method of expressing the absorbance Then, the melanin production amount relative to the control group was calculated as the inhibition rate (%) to determine the IC 50 .

【0031】 以下、本発明に係る実施例に対して説明するが、本発明の範囲がこれらの実施
例に限るものではない。
Hereinafter, examples according to the present invention will be described, but the scope of the present invention is not limited to these examples.

【0032】 実施例1.メラニン生成阻害物質の分離 五味子500gを粉砕した試料にメタノール10Lを加えて、48時間の間常温で振と
うしながら2回抽出した。抽出した後、濾紙で濾過して、50℃で減圧濃縮して濃
縮抽出物298gを得た。これにヘキサン:水:メタノール=10:9:1(V/V/V)の混
合物を2L添加してヘキサン層と水層とに分画した。A.niger胞子のメラニン合成
阻害活性を現れるヘキサン層抽出物(21.4g)をシリカゲルカラムクロマトグラフ
ィー(使用溶媒:ベンゼン:アセトン、98:2→3:7(V/V))をして200mlずつ全て1
2個の画分を得た。A.niger胞子のメラニン合成阻害活性を現れる画分2〜5を対象
に夫々メラノーマ細胞のメラニン合成阻害活性の測定を行った結果、画分3が10
μg/mlの濃度まで細胞数の減少無しにメラニン合成阻害活性を見せた。画分3(3.
1g)を逆相(Reverse phase;以下、RPと略称す)カラムクロマトグラフィ(70%メ
タノール→100%メタノール)を実施した。50mlずつ全て25個の画分を得た。その
中で、活性の強い14画分を予備TLC(ヘキサン:エチレンアセテート=6:1)で展
開してA.niger胞子のメラニン合成阻害活性を表すバンドのみを収集した。該収
集された活性バンド部分を予備HPLC(カラム:Vydac ODS、5μm、250×10mm I.
D、流動速度:2ml/分、UVデテクター:220nm、溶媒:70%アセトニトリル(aceto
nitrile))を実施して二つの化合物を分離して夫々SHC1とSHC2とに命名した。最
終分離された2種の物質の1H-NMR及び13C-NMRスペクトルを分析した結果を表1に
示した。
Example 1. Separation of Melanin-Inhibiting Substance 10 mL of methanol was added to a sample obtained by crushing 500 g of Schisandra chinensis and extracted twice with shaking at room temperature for 48 hours. After extraction, it was filtered with filter paper and concentrated under reduced pressure at 50 ° C. to obtain 298 g of concentrated extract. To this, 2 L of a mixture of hexane: water: methanol = 10: 9: 1 (V / V / V) was added to fractionate into a hexane layer and an aqueous layer. A hexane layer extract (21.4 g) showing melanin synthesis inhibitory activity of A. niger spores was subjected to silica gel column chromatography (solvent: benzene: acetone, 98: 2 → 3: 7 (V / V)) to give 200 ml each. All 1
Two fractions were obtained. Fractions 2 to 5 showing melanin synthesis inhibitory activity of A. niger spores were subjected to measurement of melanin synthesis inhibitory activity of melanoma cells.
It showed melanin synthesis inhibitory activity without decreasing the cell number up to the concentration of μg / ml. Fraction 3 (3.
1 g) was subjected to reverse phase (hereinafter abbreviated as RP) column chromatography (70% methanol → 100% methanol). A total of 25 fractions of 50 ml each were obtained. Among them, 14 highly active fractions were developed by preparative TLC (hexane: ethylene acetate = 6: 1), and only the band showing the melanin synthesis inhibitory activity of A. niger spores was collected. A portion of the collected active band was analyzed by preparative HPLC (column: Vydac ODS, 5 μm, 250 × 10 mm I.D.
D, flow rate: 2 ml / min, UV detector: 220 nm, solvent: 70% acetonitrile (aceto
nitrile)) to separate the two compounds and named them SHC1 and SHC2, respectively. Table 1 shows the results of analysis of 1 H-NMR and 13 C-NMR spectra of the two finally separated substances.

【0033】[0033]

【表1】 [Table 1]

【0034】 SHC1及びSHC2は、全て無色の油であって、EI-MS上で全てm/z400の同様な分子
量を有した。このような実験の結果に基づいて、SHC1及びSHC2は、全て、C23H28 O6の分子式を有する立体異性質体であって、SHC1はゴミシンN(gomisin N)、SHC
2はγ-シザンドリン(γ-schizandrin)に推定された。ゴミシンN及びγ-シザン
ドリンの標準フォームをHPLCで分析した結果と文献に収録されたゴミシンN及び
γ-シザンドリンの物理・化学的性質及びNMRデータとを比較することで、SHC1は
ゴミシンNで、SHC2はγ-シザンドリンであることを確認した。
SHC1 and SHC2 were all colorless oils and all had similar molecular weights on EI-MS of m / z 400. Based on such results of experiments, SHCl and SHC2 all, a three-dimensional an isomer having a molecular formula of C 23 H 28 O 6, SHC1 the Gomisin N (gomisin N), SHC
2 was estimated to be γ-schizandrin. By comparing the results of HPLC analysis of standard forms of gomisin N and γ-schizandrin with the physical and chemical properties and NMR data of gomisin N and γ-schizandrin recorded in the literature, SHC1 is gomisin N and SHC2 Was confirmed to be γ-schizandrin.

【0035】 実施例2.チロシナーゼ阻害活性の測定 実施例1から得たゴミシンN及びγ-シザンドリンを200ppmの濃度から1/2ずつ希
釈してチロシナーゼ阻害活性を測定して、陽性対照群であるコウジ酸、アルブチ
ン、p-ヒドロキシアニゾールと活性を比較した。その結果を図1に示した。図1の
黒三角はコウジ酸を、黒四角はアルブチンを、黒丸(●)はp-ヒドロキシアニゾー
ルを、白丸(○)はγ-シザンドリンを、白四角(□)はゴミシンNを夫々示したもの
で、図示されたように、コウジ酸は10ppm程度の濃度で50%以上の阻害率を示し、
アルブチンは25ppmの濃度で、p-ヒドロキシアニゾールは50ppmの濃度で50%以上
の阻害率を見せたが、ゴミシンN及びγ-シザンドリンは200ppm以上の濃度でも微
弱な活性を見せた。
Example 2. Measurement of tyrosinase inhibitory activity Gomisin N and γ-schizandrin obtained from Example 1 were diluted by 1/2 from the concentration of 200 ppm to measure tyrosinase inhibitory activity, and a positive control group, kojic acid, arbutin, p-hydroxyl. The activity was compared with anisole. The results are shown in Fig. 1. In Fig. 1, the black triangles indicate kojic acid, the black squares indicate arbutin, the black circles (●) indicate p-hydroxyanisole, the white circles (○) indicate γ-schizandrin, and the white squares (□) indicate gomisin N. As shown in the figure, kojic acid shows an inhibition rate of 50% or more at a concentration of about 10 ppm,
Arbutin showed a 50% or more inhibition rate at a concentration of 25 ppm and p-hydroxyanisole at a concentration of 50 ppm, but gomisin N and γ-schizandrin showed a weak activity at a concentration of 200 ppm or more.

【0036】 実施例3.抗酸化活性の測定 実施例1から分離したゴミシンN及びγ-シザンドリンを100μgずつ夫々リノレ
ン酸が包含された反応液に添加して24時間後の抗酸化活性を測定した。対照群と
しては、アスコルビン酸、α-トコフェロール、p-ヒドロキシアニゾールを使用
して実験した。その結果を図2に示した。図2中Aはアスコルビン酸を、Bはα-ト
コフェロールを、Cはp-ヒドロキシアニゾールを、DはゴミシンNを、Eはγ-シザ
ンドリンを夫々示したものである。実験結果、24時間後にアスコルビン酸は72%
の抗酸化活性を示し、α-トコフェロール及びp-ヒドロキシアニゾールも夫々41%
、38%の活性を示したが、ゴミシンN及びγ-シザンドリンは夫々24%、22%の活性
を示した。
Example 3. Measurement of Antioxidant Activity Gomicin N and γ-schizandrin separated from Example 1 were added to reaction solutions containing 100 μg each of linolenic acid, and antioxidant activity was measured 24 hours later. As a control group, an experiment was performed using ascorbic acid, α-tocopherol, and p-hydroxyanisole. The results are shown in Fig. 2. In FIG. 2, A is ascorbic acid, B is α-tocopherol, C is p-hydroxyanisole, D is gomisin N, and E is γ-schizandrin. Experimental results show 72% ascorbic acid after 24 hours
The antioxidative activity of α-tocopherol and p-hydroxyanisole was 41% respectively.
, 38%, but gomisin N and γ-schizandrin showed 24% and 22%, respectively.

【0037】 実施例4.ストレプトミセス・ビキニエンシス(Streptomyces bikiniensis
に対するメラニン合成阻害活性の測定 実施例1から分離したゴミシンN及びγ-シザンドリンのStreptomyces bikinie
nsisに対するメラニン合成阻害活性を測定して、その結果を表2に示した。その
結果表2に示されたように、γ-シザンドリンは、強力なメラニン生成阻害剤とし
て皮膚癌患者に対する臨床実験が実施されたp-ヒドロキシアニゾールに比べて50
μg以上の高濃度では多少活性が弱かったが、20μg付近の濃度で殆ど類似な活性
を表し、ゴミシンNはp-ヒドロキシアニゾール及びγ-シザンドリンに比べて多少
活性が微弱であるが、12.5μgの濃度まで活性が表れた。
Example 4. Streptomyces bikiniensis
Of Melanin Synthesis Inhibitory Activity Against Streptomyces bikinie of Gomisin N and γ-Schizandrin Isolated from Example 1
The melanin synthesis inhibitory activity against nsis was measured, and the results are shown in Table 2. As a result, as shown in Table 2, γ-schizandrin was used as a potent melanin production inhibitor in comparison with p-hydroxyanizole, which has been clinically tested in skin cancer patients.
Although the activity was slightly weaker at a high concentration of μg or more, it showed almost similar activity at a concentration of about 20 μg, and gomisin N had a slightly weaker activity than p-hydroxyanisole and γ-schizandrin, but 12.5 μg The activity was exhibited up to the concentration of.

【0038】[0038]

【表2】 [Table 2]

【0039】 実施例5.アスペスギリン(aspergillin)合成阻害活性 24ウェルプレートにA.nigerの胞子懸濁液に添加されたPDA培地を分注し、固め
てその表面に実施例1から分離されたゴミシンN及びγ-シザンドリンを夫々500μ
g/mlの濃度から段階的にエタノールで希釈して処理した後、胞子の色素合成を肉
眼で観察して、その結果を図3に示した。図3中、Cは100%のエタノール、Hはp-ヒ
ドロキシアニゾールを、GはゴミシンNを、Sはγ-シザンドリンを夫々示したもの
である。37℃で2日間培養した後、ゴミシンN及びγ-シザンドリンは両方とも12
0μg/ml濃度で活性を表し、対照群のp-ヒドロキシアニゾール処理群では60μg/m
lの濃度でも強い活性を表した。併し、ゴミシンN及びγ-シザンドリンは、500μ
g/ml以上の濃度でもA.nigerに対する抗菌活性無しに胞子の色素合成のみを阻害
するに比べて、p-ヒドロキシアニゾールの場合、500μg/ml及び250μg/mlの濃度
処理群でA.nigerに対する細胞毒性が観察された。
Example 5. Aspergillin synthesis inhibitory activity PDA medium added to a spore suspension of A. niger was dispensed into a 24-well plate, solidified, and then gomisin N and γ-schizandrin isolated from Example 1 were respectively attached to the surface. 500μ
After stepwise dilution with ethanol from a concentration of g / ml and treatment, spore pigment synthesis was visually observed, and the results are shown in FIG. In FIG. 3, C is 100% ethanol, H is p-hydroxyanisole, G is gomisin N, and S is γ-schizandrin. After culturing at 37 ℃ for 2 days, both gomisin N and γ-schizandrin were 12
It exhibited activity at a concentration of 0 μg / ml, and 60 μg / m in the control group treated with p-hydroxyanisole.
It showed strong activity even at a concentration of l. However, Gomisin N and γ-schizandrin were 500μ
Compared to the inhibition of spore pigment synthesis without antibacterial activity against A. niger even at a concentration of g / ml or higher, p-hydroxyanizole showed that A.niger in the concentration-treated groups of 500 μg / ml and 250 μg / ml. Cytotoxicity was observed.

【0040】 実施例6.メラニン合成阻害活性の測定 B16マウスメラノーマ細胞にゴミシンN及びγ-シザンドリンを10μg/ml及び20
μg/mlの濃度に処理して培養して細胞を遠心分離して肉眼で観察した結果、10μ
g/mlの濃度でも陽性対照群として使用されたアルブチン100μg/ml濃度処理群で
見られる活性よりもっと強い活性をみせるだけでなく、100μg/ml以上の濃度で
も細胞毒性が観察されなかった。その結果を図4に示した(SHC1:ゴミシンN、SHC
2:γ-シザンドリン)。五味子から分離した物質は、細胞に損傷を与えることな
く、強いメラニン合成阻害効果を有すると判断された。
Example 6. Measurement of melanin synthesis inhibitory activity B16 mouse melanoma cells were treated with gomisin N and γ-schizandrin at 10 μg / ml and 20
The cells were treated at a concentration of μg / ml, cultured, and the cells were centrifuged and visually observed.
At the concentration of g / ml, arbutin showed a stronger activity than that of the 100 μg / ml concentration-treated group used as a positive control group, and no cytotoxicity was observed at a concentration of 100 μg / ml or more. The results are shown in Fig. 4 (SHC1: Gomisin N, SHC
2: γ-schizandrin). The substance separated from Schisandra chinensis was judged to have a strong melanin synthesis inhibitory effect without damaging cells.

【0041】 又、ゴミシンNを処理した細胞からメラニンを抽出した後、メラニン生成量を
測定してIC50を計算すると、その値が10μg/mlであって、該アルブチンのIC50
は、300μg/mlで、ゴミシンNはメラニン合成を抑制する強力な美白化合物である
ことが分かる。
Further, when melanin was extracted from cells treated with gomisin N, the amount of melanin produced was measured to calculate the IC 50 , and the value was 10 μg / ml, and the IC 50 value of the arbutin was 300 μg. At / ml, Gomisin N is found to be a powerful whitening compound that inhibits melanin synthesis.

【0042】 実施例7.アレルギー誘発の測定 ゴミシンNを夫々15mgずつ塗布した後、8mmフィンチャンバ(Finn chamber)
を健康な男女40名を選択して腕の前部に24時間の間附着させた後、除去した。2
時間経過後、皮膚の反応程度を肉眼で観察してCTFA(The Cosmetic、Toiletry
and Fragrance Association Inc.)の基準に従って次のように判定し、皮膚の
刺激度は、被験者の判定値を全て合算した後、被験者数で除して計算した。
Example 7. Measurement of allergy induction After applying 15 mg each of Gomisin N, 8 mm fin chamber
40 healthy men and women were attached to the front part of the arm for 24 hours and then removed. 2
After a lapse of time, the degree of skin reaction is visually observed and CTFA (The Cosmetic, Toiletry
and Fragrance Association Inc.), the skin irritation degree was calculated by dividing all the judgment values of the subjects and then dividing by the number of subjects.

【0043】[0043]

【表3】 [Table 3]

【0044】 皮膚刺激度が3.0位かである場合は、アレルギー反応が発生しなかったが、ゴ
ミシンNの皮膚刺激度は、2.0であった。
When the degree of skin irritation was about 3.0, no allergic reaction occurred, but the degree of skin irritation of gomisin N was 2.0.

【0045】 以上説明したように、本発明に係るメラニン合成阻害物質及び該メラニン合成
阻害物質を含有する組成物においては、美白効果が優秀で、細胞の毒性を低下し
得るという効果がある。
As described above, the melanin synthesis inhibitory substance and the composition containing the melanin synthesis inhibitory substance according to the present invention have an excellent whitening effect and can reduce cell toxicity.

【0046】 且つ、本発明に係るメラニン合成阻害物質及び該メラニン合成阻害物質を含有
する組成物においては、化粧品、医薬用美白剤、医薬部外品及び食品褐斑防止剤
などに利用し得るという効果がある。
In addition, the melanin synthesis inhibitory substance according to the present invention and the composition containing the melanin synthesis inhibitory substance can be used for cosmetics, medicated whitening agents, quasi-drugs, food brown spot inhibitors and the like. effective.

【図面の簡単な説明】[Brief description of drawings]

【図1】 本発明に係るゴミシン及びγ-シザンドリンのチロシナーゼ活性の抑制効果を
示したグラフである。
FIG. 1 is a graph showing the inhibitory effect of tyrosinase activity of gomisin and γ-schizandrin according to the present invention.

【図2】 ゴミシンN及びγ-シザンドリンの抗酸化活性を示したグラフである。[Fig. 2]   5 is a graph showing the antioxidant activity of gomisin N and γ-schizandrin.

【図3】 ゴミシンN及びγ-シザンドリンのアスペルギリン(aspergillin)合成阻害活性
を示した写真である。
FIG. 3 is a photograph showing aspergillin synthesis inhibitory activity of gomisin N and γ-schizandrin.

【図4】 ゴミシンN及びγ-シザンドリンの試験管内の細胞培養の合成阻害活性を示した
写真である。
FIG. 4 is a photograph showing the inhibitory activity of gomisin N and γ-schizandrin on the in vitro cell culture synthesis.

───────────────────────────────────────────────────── フロントページの続き (51)Int.Cl.7 識別記号 FI テーマコート゛(参考) A61P 17/00 A61P 17/00 C07D 317/70 C07D 317/70 (81)指定国 EP(AT,BE,CH,CY, DE,DK,ES,FI,FR,GB,GR,IE,I T,LU,MC,NL,PT,SE,TR),OA(BF ,BJ,CF,CG,CI,CM,GA,GN,GW, ML,MR,NE,SN,TD,TG),AP(GH,G M,KE,LS,MW,MZ,SD,SL,SZ,TZ ,UG,ZW),EA(AM,AZ,BY,KG,KZ, MD,RU,TJ,TM),AE,AG,AL,AM, AT,AU,AZ,BA,BB,BG,BR,BY,B Z,CA,CH,CN,CR,CU,CZ,DE,DK ,DM,DZ,EE,ES,FI,GB,GD,GE, GH,GM,HR,HU,ID,IL,IN,IS,J P,KE,KG,KP,KZ,LC,LK,LR,LS ,LT,LU,LV,MA,MD,MG,MK,MN, MW,MX,MZ,NO,NZ,PL,PT,RO,R U,SD,SE,SG,SI,SK,SL,TJ,TM ,TR,TT,TZ,UA,UG,US,UZ,VN, YU,ZA,ZW (72)発明者 ジュン,ヒュン,オー 大韓民国,テジョン 305−301,ユーソン −ク,ボンミュン−ドン 161−5 (72)発明者 リー,チャン,ホ 大韓民国,テジョン 302−181,ソ−ク, ネ−ドン 220−2,ロッテ アパートメ ント 106−1201 (72)発明者 キム,ヨウン,ホ 大韓民国,テジョン 305−390,ユーソン −ク,ジュンミン−ドン,チョウングナレ アパートメント 108−202 (72)発明者 ホン,セウン,スー 大韓民国,テジョン 305−390,ユーソン −ク,ジュンミン−ドン 462−2,チョ ウングナレ アパートメント 109−404 (72)発明者 リー,ヒュン−ソー 大韓民国,ソウル 137−040,ソチョ− ク,バンポ−ドン 550−18,ジェウォー ハウス 101 Fターム(参考) 4C083 AA111 CC01 EE16 4C086 AA01 AA02 BA13 MA01 MA04 NA14 ZA89 ZC02 4C088 AB65 BA08 CA14 NA14 ZA89 ZC02 ─────────────────────────────────────────────────── ─── Continuation of front page (51) Int.Cl. 7 Identification code FI theme code (reference) A61P 17/00 A61P 17/00 C07D 317/70 C07D 317/70 (81) Designated country EP (AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE, TR), OA (BF, BJ, CF, CG, CI, CM, GA, GN, GW, ML, MR, NE, SN, TD, TG), AP (GH, GM, KE, LS, MW, MZ, SD, SL, SZ, TZ, UG, ZW), EA (AM , AZ, BY, KG, KZ, MD, RU, TJ, TM), AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, BZ CA, CH, CN, CR, CU, CZ, DE, DK, DM, DZ, EE, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP , KE, KG, KP, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NO, NZ, PL, PT, RO, R U, SD, SE, SG, SI, SK, SL, TJ, TM, TR, TT, TZ, UA, UG, US, UZ, VN, YU, ZA, ZW (72) Inventor Jun, Hyun, Oh Republic of Korea , Taejong 305-301, Yousung-ku, Bonmung-dong 161-5 (72) Inventor Lee, Chang, Ho South Korea, Taejong 302-181, Souk, Naedon 220-2, Lotte apartment 106- 1201 (72) Inventor Kim, Yoon, Ho, Taejeong, Republic of Korea 30 5-390, Yousung-ku, Junmin-dong, Choengnare Apartment 108-202 (72) Inventor Hong, Seung, Sue South Korea, Daejeong 305-390, Yousung-ku, Junmin-dong 462-2, Choungnare Apartment 109- 404 (72) Inventor Lee, Hyun-soo Korea, Seoul 137-040, Seochok, Banpo Dong 550-18, Jewo House 101 F Term (Reference) 4C083 AA111 CC01 EE16 4C086 AA01 AA02 BA13 MA01 MA04 NA14 ZA89 ZC02 4C088 AB65 BA08 CA14 NA14 ZA89 ZC02

Claims (8)

【特許請求の範囲】[Claims] 【請求項1】 ゴミシンN又はγ-シザンドリンを含有する、メラニン合成阻
害組成物。
1. A melanin synthesis inhibitory composition containing gomisin N or γ-schizandrin.
【請求項2】 前記組成物が美白剤である、請求項1に記載の組成物。2. The composition according to claim 1, wherein the composition is a whitening agent. 【請求項3】 前記組成物が化粧品である、請求項2に記載の組成物。3. The composition of claim 2, wherein the composition is cosmetic. 【請求項4】 前記組成物が医薬用美白剤である、請求項2に記載の組成物
4. The composition of claim 2, wherein the composition is a pharmaceutical whitening agent.
【請求項5】 前記組成物が食品の褐斑防止剤である、請求項2に記載の組
成物。
5. The composition according to claim 2, wherein the composition is a food browning agent.
【請求項6】 前記組成物が五味子に由来する、請求項1に記載の組成物。6. The composition according to claim 1, wherein the composition is derived from Schisandra chinensis. 【請求項7】 五味子抽出物を含み、かつ、美白効果に十分な量のゴミシン
Nを含有する、美白効果を有する組成物。
7. Gomishin containing Gomiza extract and in an amount sufficient for a whitening effect
A composition containing N, which has a whitening effect.
【請求項8】 カラムクロマトグラフィーにより五味子抽出物からの画分を
得、そして該得られた画分からゴミシンN含有画分を回収するステップにより製
造されるゴミシンN含有組成物。
8. A gomisin N-containing composition produced by a step of obtaining a fraction from a garlic extract by column chromatography, and collecting the gomisin N-containing fraction from the obtained fraction.
JP2001543122A 1999-12-08 2000-12-07 Melanin synthesis inhibitory compound and composition containing the melanin synthesis inhibitory compound Withdrawn JP2003516358A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
KR1019990055670A KR100344751B1 (en) 1999-12-08 1999-12-08 Melanin synthesis inhibiting compound and composition containing the same
KR1999/55670 1999-12-08
PCT/KR2000/001420 WO2001041778A1 (en) 1999-12-08 2000-12-07 Melanin synthesis inhibition compound and composition containing the same

Publications (1)

Publication Number Publication Date
JP2003516358A true JP2003516358A (en) 2003-05-13

Family

ID=19624152

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2001543122A Withdrawn JP2003516358A (en) 1999-12-08 2000-12-07 Melanin synthesis inhibitory compound and composition containing the melanin synthesis inhibitory compound

Country Status (4)

Country Link
JP (1) JP2003516358A (en)
KR (1) KR100344751B1 (en)
AU (1) AU2026801A (en)
WO (1) WO2001041778A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2012511532A (en) * 2008-12-10 2012-05-24 ユニリーバー・ナームローゼ・ベンノートシヤープ Skin lightening composition comprising an acetylcholinesterase inhibitor

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004244326A (en) * 2003-02-12 2004-09-02 Ichimaru Pharcos Co Ltd Bleaching agent and bleaching cosmetic
US20070128302A1 (en) * 2003-11-07 2007-06-07 Cognis France S.A. Composition containing an extract of the fruit of schisandra chinensis and process for producing same
CN101042380A (en) * 2007-04-27 2007-09-26 上海现代中医药技术发展有限公司 Method for measuring strengthen the body resistance and absorbing clots plant medicine plasma gamma-schizandrin
CN101334386B (en) 2007-04-27 2012-07-11 上海现代中医药股份有限公司 Determination method for plant medicine blood plasma amygdalin for strengthening the body resistance
CN101078712A (en) 2007-04-27 2007-11-28 上海现代中医药技术发展有限公司 Method for determining plasma tanshinol and salvianolic acid B for strengthening body resistance and eliminating stasis
CN101045092A (en) 2007-04-29 2007-10-03 上海现代中医药技术发展有限公司 Application of plant medicine composition for strengthening the body resistance and resolving stagnate
WO2017014597A1 (en) * 2015-07-23 2017-01-26 동국대학교 산학협력단 Cosmetic composition for improving skin whitening containing schisandra chinensis seed extract
KR101807548B1 (en) * 2015-10-30 2018-01-18 한국콜마주식회사 Whitening cosmetic compositions containing nano liposome included extract of schisandra chinensis and manufacturing method of its nano liposome

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6042485A (en) * 1983-08-17 1985-03-06 Osaka Chem Lab Antioxidant
JPS6416721A (en) * 1987-07-09 1989-01-20 Tsumura & Co Antioxidant

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2012511532A (en) * 2008-12-10 2012-05-24 ユニリーバー・ナームローゼ・ベンノートシヤープ Skin lightening composition comprising an acetylcholinesterase inhibitor

Also Published As

Publication number Publication date
KR20010054727A (en) 2001-07-02
KR100344751B1 (en) 2002-07-20
WO2001041778B1 (en) 2001-10-25
AU2026801A (en) 2001-06-18
WO2001041778A1 (en) 2001-06-14

Similar Documents

Publication Publication Date Title
KR100504408B1 (en) Cosmetic Composition for Skin-Whitening Comprising Senkyunolide A as Active Ingredient
JP2003516358A (en) Melanin synthesis inhibitory compound and composition containing the melanin synthesis inhibitory compound
AU2015262386A1 (en) Novel Uses of Rose Pigment Compounds
KR102436291B1 (en) Cosmetic Composition for Skin Whitening Containing Eleutheroside E As Active Ingredient
KR100361592B1 (en) An extract of angelica dahurica and angelica tenuissima and a cosmetic composition therefrom
KR100905388B1 (en) Leaf extract of fragaria ananassa duchesne complex having skin whitening activity containing ellagic acid
KR20140097865A (en) Cosmetic composition comprising Laver extract for anti-inflammation
JP5154835B2 (en) Whitening cosmetics
KR20110075743A (en) Cosmetic composition containing whitening composition for whitening skin
KR101854766B1 (en) Skin whitening complex containing trihydroxyisoflavone and glycyrrhiza uralensis extracts
KR20090117364A (en) Cosmetic composition for whitening of the skin comprising the extract of brucea javanica as active ingredient
KR100681700B1 (en) Cosmetic composition for skin whitening comprising senkyunolide a and gluconic acid as active ingredients
JP2000239145A (en) Anti-allergic agent, beautifully whitening agent and skin cosmetic
KR101948661B1 (en) Cosmetic composition for skin whitening containing magnolia sieboldii extract ripened at low-temperature using bamboo charcoal
KR101069906B1 (en) A composition for improving skin conditions comprising extract of Aster subulatus Michx.
JP5946510B2 (en) Melanin production inhibitor, cosmetic, and method for producing melanin production inhibitor
KR101731264B1 (en) Skin brightening cosmetic composition with the extract of rhizomes of Belamcanda chinensis by subcritical water extraction
JPH06166609A (en) Whitening and beautifying agent
KR101708284B1 (en) Cosmetic composition for skin whitening and anti-wrinkle effect comprising Scirpus wichurai extract as effective component
JP4402278B2 (en) Whitening cosmetics
TWI477292B (en) Flatstem milkvetch seed extract for preventing melanin precipitation
KR20180064848A (en) Compositions for improving skin whitening and skin wrinkle comprising physiologically active substances derived from extract of cynanchum filfordii
KR102092221B1 (en) Compositions for improving skin whitening and skin hyperkeratosis comprising physiologically active substances derived from extract of puerariae caulis
KR20110064292A (en) Cosmetic composition containing rucinol and polygonum multiflorum extracts for skin whitening
KR20070095715A (en) A composition for external application for skinwhitening containing extract of seeds of cassia tora or emodin isolated therefrom

Legal Events

Date Code Title Description
A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20060221

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20060411

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20060710

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20060719

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20061011

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20061011

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20071204

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20080402

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20080410

A911 Transfer of reconsideration by examiner before appeal (zenchi)

Free format text: JAPANESE INTERMEDIATE CODE: A911

Effective date: 20080514

A912 Removal of reconsideration by examiner before appeal (zenchi)

Free format text: JAPANESE INTERMEDIATE CODE: A912

Effective date: 20080627

A761 Written withdrawal of application

Free format text: JAPANESE INTERMEDIATE CODE: A761

Effective date: 20090108